Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ray Kurzweil currently holds 12,670 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ray Kurzweil has been a net seller of UTHR stock. They have purchased $0 and sold $12.8M worth of shares.
Ray Kurzweil's most recent insider trade was on Jul 25, 2025, when they sold 590 shares at $0.00 per share.
Ray Kurzweil serves as Executive at UNITED THERAPEUTICS Corp (UTHR). They have executed 64 insider transactions totaling $12.8M over their tenure at the company.
Ray Kurzweil holds the position of Executive at UNITED THERAPEUTICS Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Ray Kurzweil has shown a selling trading pattern, with $0 in total purchases and $12.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ray Kurzweil was on Feb 23, 2024, when they sold $3.4M worth of UTHR shares. This transaction involved 15,000 shares at $227.03 per share.
Ray Kurzweil currently owns 12,670 shares of UNITED THERAPEUTICS Corp (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ray Kurzweil's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ray Kurzweil has 64 Form 4 filings on record as an insider at UNITED THERAPEUTICS Corp.
Set alerts for Ray Kurzweil and 40,000+ other insiders.